$TRDA 4/A SEC Filings

Filed On	Filing
18 Jun 2025	Form 4/A: Kim Peter S, Director Bought 25,000 shares ($367K) · Bought 25,000 shares ($365K)
19 Apr 2023	Form 4/A: Doshi Dipal, Director Received 49,650 shares as a grant or award · Granted 75,250 Stock Option (Right to Buy)
19 Apr 2023	Form 4/A: Sethuraman Natarajan, Chief Scientific Officer Received 14,200 shares as a grant or award · Granted 21,500 Stock Option (Right to Buy)
19 Apr 2023	Form 4/A: Wentworth Kory James, Chief Financial Officer Received 14,200 shares as a grant or award · Granted 21,500 Stock Option (Right to Buy)
19 Apr 2023	Form 4/A: Kreher Nerissa, Chief Medical Officer Received 14,200 shares as a grant or award · Granted 21,500 Stock Option (Right to Buy)
19 Apr 2023	Form 4/A: Dowden Nathan J, Chief Operating Officer Received 14,200 shares as a grant or award · Granted 21,500 Stock Option (Right to Buy)

Comments